Fresenius Medical Care AG & Co. KGaA ( NYSE:FMS – Get Free Report ) was downgraded by Barclays from an “equal weight” rating to an “underweight” rating in a research note issued on Monday, MarketBeat reports.
Other equities analysts have also issued reports about the company. Weiss Ratings raised Fresenius Medical Care AG & Co. KGaA from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Truist Financial dropped their price target on Fresenius Medical Care AG & Co. KGaA from $25.00 to $24.00 and set a “hold” rating on the stock in a report on Monday, October 12th. Zacks Research downgraded Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. Sanford C. Bernstein increased their price target on Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the company a “market perform” rating in a research report on Thursday, August 6th. Finally, BNP Paribas Exane lowered Fresenius Medical Care AG & Co. KGaA from a “neutral” rating to an “underperform” rating and set a $19.90 price target for the company. in a research report on Tuesday, July 28th. Seven equities research analy...